-

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Silicon Motion Technology Corporation (SIMO)

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming October 30, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Silicon Motion Technology Corporation (“Silicon Motion” or the “Company”) (NASDAQ: SIMO) American Depositary Shares (“ADSs”) between June 6, 2023 and July 26, 2023, inclusive (the “Class Period”).

Investors suffering losses on their Silicon Motion investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in this class action at 888-638-4847 or by email to howardsmith@howardsmithlaw.com.

On July 26, 2023, MaxLinear announced that it was terminating a merger agreement with Silicon Motion less than a day after Chinese regulatory authorities had approved the combination.

On this news, Silicon Motion’s stock price fell $12.84, or 19.6%, to close at $52.51 per ADS on July 27, 2023, thereby injuring investors.

The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) there had been a material downturn in the semiconductor industry and rising interest rates; (2) MaxLinear had determined to unilaterally terminate the Merger in the event the Merger was approved by Chinese regulatory authorities; (3) MaxLinear intended to argue that certain conditions in Article 6 of the Merger Agreement had not been satisfied as required by May 5, 2023 (i.e., before the Class Period) as a basis to terminate the Merger; and (4) as a result of the foregoing, defendants had materially misrepresented the viability of the Merger, the purported benefits of the Merger, and the likelihood that the Merger would be consummated; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.

If you purchased or otherwise acquired Silicon Motion ADSs during the Class Period, you may move the Court no later than October 30, 2023 to ask the Court to appoint you as lead plaintiff if you meet certain legal requirements. To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020, by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Law Offices of Howard G. Smith

NASDAQ:SIMO

Release Versions

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
888-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC. (UPC) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces it is investigating potential claims against the board of directors of Universe Pharmaceuticals INC. ("Universe Pharmaceuticals" or the "Company") (NASDAQ: UPC) concerning whether the board breached its fiduciary duties to shareholders. IF YOU ARE A UNIVERSE PHARMACEUTICALS INC. (UPC) SHAREHOLDER, CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO PARTICIPATE. Contact Us To Participate or Learn More: If you still hold Universe...

Law Offices of Howard G. Smith Encourages The Chemours Company (CC) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Chemours Company (“Chemours” or the “Company”) (NYSE: CC) common stock between February 20, 2026 and August 4, 2026, inclusive (the “Class Period”). Chemours investors have until December 7, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CHEMOURS COMPANY (CC), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO...

Law Offices of Howard G. Smith Encourages The Ensign Group, Inc. (ENSG) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased The Ensign Group, Inc. (“Ensign” or the “Company”) (NASDAQ: ENSG) common stock between February 10, 2022 and June 18, 2026, inclusive (the “Class Period”). Ensign investors have until December 7, 2026 to file a lead plaintiff motion.IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN THE ENSIGN GROUP, INC. (ENSG), CONTACT THE LAW OFFICES OF HOWARD G....
Back to Newsroom